80 related articles for article (PubMed ID: 1297297)
1. [Intravenous thrombolysis by recombinant plasminogen activator (rt-PA) in unstable angina. A randomized multicenter study versus placebo].
Charbonnier B; Bernadet P; Schiele F; Thery C; Baudouy M; Bauters C
Arch Mal Coeur Vaiss; 1992 Oct; 85(10):1471-7. PubMed ID: 1297297
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of prolonged low dose recombinant tissue-type plasminogen activator for refractory unstable angina.
Romeo F; Rosano GM; Martuscelli E; Comito M; Cardona N; Colistra C; Milano B; Bianco C; Rosano V
J Am Coll Cardiol; 1995 May; 25(6):1295-9. PubMed ID: 7722124
[TBL] [Abstract][Full Text] [Related]
3. [The safety and efficacy of systemic salvage thrombolysis in acute myocardial infarct].
Sarullo FM; Schicchi R; Schirò M; Americo L; Bonnì G; Faraone N; Di Pasquale P; Castello A; Mauri F
Ital Heart J Suppl; 2000 Jan; 1(1):81-7. PubMed ID: 10832123
[TBL] [Abstract][Full Text] [Related]
4. [Study of new thrombolytic agents in myocardial infarction: a multicenter randomized trial (APSAC versus rt-PA)].
Cassagnes J; Machecourt J; Bassand JP; Lusson JR; Wolf JE; Anguenot T; Maublant J; Fagret D; Cardot JC
Arch Mal Coeur Vaiss; 1992 Nov; 85(11):1593-9. PubMed ID: 1300957
[TBL] [Abstract][Full Text] [Related]
5. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
[TBL] [Abstract][Full Text] [Related]
6. The effect of preinfarction angina on clinical reperfusion time in patients with acute myocardial infarction receiving successful thrombolytic therapy.
Evrengul H; Celek T; Tanriverdi H; Kaftan A; Dursunoglu D; Kilic M
Can J Cardiol; 2005 Sep; 21(11):915-20. PubMed ID: 16239974
[TBL] [Abstract][Full Text] [Related]
7. Clopidogrel-rt-PA-heparin combination in the treatment of acute myocardial infarction.
Bassand JP; Cariou R; Grollier G; Kragten J; Wolf JE; Heyndrickx GR
Semin Thromb Hemost; 1999; 25 Suppl 2():69-75. PubMed ID: 10440428
[TBL] [Abstract][Full Text] [Related]
8. [Intravenous recombinant tissue-type plasminogen activator in acute myocardial infarction].
Gao R
Zhonghua Xin Xue Guan Bing Za Zhi; 1991 Aug; 19(4):228-30, 267-8. PubMed ID: 1813288
[TBL] [Abstract][Full Text] [Related]
9. Thrombolysis in unstable angina. Randomized double-blind trial of t-PA and placebo.
Freeman MR; Langer A; Wilson RF; Morgan CD; Armstrong PW
Circulation; 1992 Jan; 85(1):150-7. PubMed ID: 1728444
[TBL] [Abstract][Full Text] [Related]
10. Treatment of acute myocardial infarction with recombinant tissue-type plasminogen activator.
Glazier JJ; Crowley J; Cremin D; Coll T; Daly K
Ir Med J; 1989 Sep; 82(3):111-4. PubMed ID: 2513287
[TBL] [Abstract][Full Text] [Related]
11. Graded exercise testing following thrombolytic therapy for acute myocardial infarction: the importance of timing and infarct location. TPAT Study Group.
Morgan CD; Gent M; Daly PA; Baigrie RS; Haq A; Roberts RS; Armstrong PW
Can J Cardiol; 1994 Nov; 10(9):897-904. PubMed ID: 7954025
[TBL] [Abstract][Full Text] [Related]
12. Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trial.
Williams DO; Topol EJ; Califf RM; Roberts R; Mancini GB; Joelson JM; Ellis SG; Kleiman NS
Circulation; 1990 Aug; 82(2):376-83. PubMed ID: 2115407
[TBL] [Abstract][Full Text] [Related]
13. Coronary revascularization after intravenous tissue plasminogen activator for unstable angina pectoris: results of a randomized, double-blind, placebo-controlled trial.
Topol EJ; Nicklas JM; Kander NH; Walton JA; Ellis SG; Gorman L; Pitt B
Am J Cardiol; 1988 Sep; 62(7):368-71. PubMed ID: 2970776
[TBL] [Abstract][Full Text] [Related]
14. Randomized, double-blind, placebo-controlled trial of tissue plasminogen activator in unstable angina.
Nicklas JM; Topol EJ; Kander N; O'Neill WW; Walton JA; Ellis SG; Gorman L; Pitt B
J Am Coll Cardiol; 1989 Feb; 13(2):434-41. PubMed ID: 2492325
[TBL] [Abstract][Full Text] [Related]
15. A randomized, blinded, placebo-controlled trial of recombinant human tissue-type plasminogen activator in patients with unstable angina pectoris.
Gold HK; Johns JA; Leinbach RC; Yasuda T; Grossbard E; Zusman R; Collen D
Circulation; 1987 Jun; 75(6):1192-9. PubMed ID: 3105913
[TBL] [Abstract][Full Text] [Related]
16. Recombinant tissue-type plasminogen activator followed by heparin compared with heparin alone for refractory unstable angina pectoris.
Ardissino D; Barberis P; De Servi S; Mussini A; Rolla A; Visani L; Specchia G
Am J Cardiol; 1990 Oct; 66(12):910-4. PubMed ID: 2121016
[TBL] [Abstract][Full Text] [Related]
17. Tissue plasminogen activator in refractory unstable angina. A randomized double-blind placebo-controlled trial in patients with refractory unstable angina and subsequent angioplasty.
van den Brand M; van Zijl A; Geuskens R; de Feyter PJ; Serruys PW; Simoons ML
Eur Heart J; 1991 Nov; 12(11):1208-14. PubMed ID: 1782951
[TBL] [Abstract][Full Text] [Related]
18. Tissue plasminogen activator using a rapid-infusion low-dose regimen for unstable angina.
Chaudhary H; Crozier I; Hamer A; Foy S; Shirlaw T; Ikram H
Am J Cardiol; 1992 Jan; 69(3):173-5. PubMed ID: 1731454
[TBL] [Abstract][Full Text] [Related]
19. Intracoronary recombinant tissue-type plasminogen activator in unstable angina: a pilot angiographic study.
DiSciascio G; Kohli RS; Goudreau E; Sabri N; Vetrovec GW
Am Heart J; 1991 Jul; 122(1 Pt 1):1-6. PubMed ID: 1905873
[TBL] [Abstract][Full Text] [Related]
20. Thrombolysis with recombinant human tissue-type plasminogen activator during instability in coronary artery disease: effect on myocardial ischemia and need for coronary revascularization. TRIC Study Group.
Karlsson JE; Berglund U; Björkholm A; Ohlsson J; Swahn E; Wallentin L
Am Heart J; 1992 Dec; 124(6):1419-26. PubMed ID: 1462894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
